RE:RE:RE:Company Webinar
gebremeskel wrote: A waste of 20 minutes.
Other than some good details from Ms. Hachey about funding, no shareholder concerns were addressed.
Mr. Dumoulin-White seemed to just be reading aloud from the news releases.
Pointless.
steamfitter wrote: Nothing NEW Was reported
Everything said we all know about. Let's hope a release will come this week for more on TLT.
Roger's "how does Ruvidar stack up against the competition?" Question had me laugh out loud. No one on this board would ask that. And it's already been dissected and answered by our own board members because Theralase couldn't even put the data together in a coherent manner.
It's hard to be disappointed when you expect nothing but TLT keeps delivering
not bashing, still loving